Intravitreal Infliximab for Sight-Threatening Relapsing Uveitis in Behçet Disease: A Pilot Study in 15 Patients
Purpose To assess the safety and to conduct a preliminary assessment of efficacy of intravitreal infliximab, an anti–tumor necrosis factor antibody, for sight-threatening relapsing uveitis in Behçet disease. Design Prospective,…